SCHEMBL21481374

SCHEMBL21481374

c1ccc(-c2ccc(-n3c4ccccc4c4cc(-c5ccc(-c6ccc7c(c6)c6ccccc6n7-c6ccc7oc8ccccc8c7c6)cc5)ccc43)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PLA2G2A P14555 5/20 0.43
PLA2G4A P47712 5/20 0.43
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PLA2G10 O15496 1/20 0.39
TSPO P30536 1/20 0.38
HDAC4 P56524 1/20 0.38
PRKDC P78527 3/20 0.36
PTPN1 P18031 1/20 0.36
EDNRB P24530 1/20 0.36
EDNRA P25101 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20633757 1.00 KDM4E (0.44) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL25941212 1.00 KDM4E (0.44) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL14212273 1.00 KDM4E (0.44) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL26060207 0.99 KDM4E (0.46) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL18265978 0.99 KDM4E (0.46) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL14733865 0.99 KDM4E (0.46) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL20706752 0.99 PLA2G2A (0.44) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL20633659 0.99 PLA2G2A (0.44) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL18266011 0.99 PLA2G2A (0.44) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL18266070 0.99 PLA2G2A (0.44) KDM4EATML3MBTL1PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 US disclosed
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 US disclosed
US-20190319197-A1 ORGANIC COMPOUND, APPLICATIONS THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2019-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190319197-A1 ORGANIC COMPOUND, APPLICATIONS THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE PIEZO1, OR10J3, OR51E2 KDM4E 2904/4885ATM 2334/4885L3MBTL1 1968/4885
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF AOX1, ODC1, OTC KDM4E 4036/4885ATM 2511/4885L3MBTL1 2702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.